Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Digestive system neuroendocrine neoplasm
Digestive system neuroendocrine tumor, grade 1/2
A well-differentiated neuroendocrine tumor arising from the digestive system. It is characterized by the presence of cells with features similar to those of the normal endocrine cells of the digestive system. The neoplastic cells express immunohistochemical evidence of neuroendocrine differentiation and hormones. There is mild to moderate nuclear atypia and less than 20 mitoses per 10 HPF. It includes well-differentiated endocrine tumors or carcinoid tumors and well-differentiated endocrine carcinomas.
-
Pancreatic neuroendocrine tumor 60 trials · 77 incl. sub-types Sub-types →
-
Small intestine neuroendocrine tumor, well differentiated, low or intermediate grade 4 trials · 9 incl. sub-types Sub-types →
-
Intestinal neuroendocrine tumor G1 5 trials · 8 incl. sub-types Sub-types →
-
Neuroendocrine tumor of the colon, well differentiated, low or intermediate grade tumor 0 trials · 5 incl. sub-types Sub-types →
-
Rectal neuroendocrine tumor 3 trials · 4 incl. sub-types Sub-types →
-
Gastric neuroendocrine tumor, well differentiated, low or intermediate grade 2 trials · 4 incl. sub-types Sub-types →
-
Esophageal neuroendocrine tumor 1 trial · 3 incl. sub-types Sub-types →